United States · FDA National Drug Code directory
TADALAFIL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-581_1f85153f-5d3a-40d8-8570-1d969f4efa3c
- Product NDC
- 13668-581
- Form
- TABLET
- Composition / generic term
- TADALAFIL
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190326
- Source listing expiry
- 20271231
Source-listed ingredients
- TADALAFIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (13668-581-30) · 13668-581-30
- 60 TABLET in 1 BOTTLE (13668-581-60) · 13668-581-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →